School of Medicine
Showing 2,321-2,340 of 2,382 Results
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research lab focused on using large database analyses and novel scalable approaches to improve the quality of cardiovascular care. In her clinical practice, Dr. Yong performs complex percutaneous coronary interventions and transcatheter aortic valve replacements. She is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease. She serves as an Associate Editor for the Journal of the American College of Cardiology and leads the VA-Cardiovascular Trials Consortium. She has co-authored national guidelines and scientific statements, including the ACC/AHA/SCAI Coronary Revascularization Guidelines.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, followed by internal medicine residency at University of California, San Francisco and cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
-
Grace Chen Yu
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Yu is a modern-day version of the “old-fashioned family doc” who delights in caring for patients from “cradle to grave,” while also promoting the health of her community and developing the future leaders of family medicine. On any particular day, one might find her counseling a long-time smoker on quitting, draining an abscess in clinic, delivering a baby, doing a phone (or sometimes home) visit with one of her elderly patients, lecturing about High-Value Health Care, facilitating a diabetes group visit, singing the praises of coordinated primary care to politicians, discussing end-of-life options with a hospitalized patient, or sharing some of her stories as mother-doctor-teacher with one of her advisees. In 2016, adding one more hat to the mix, Dr. Yu became Program Director of the 24-resident Stanford Health Care - O’Connor Hospital Family Medicine Residency Program. Whereas the old-fashioned family doc was a master at caring for patients at different ages and stages of life, as a modern-day family physician, Dr. Yu is committed to researching ways to do so more effectively and efficiently. She considers it a privilege to be a part of her patients' lives and hopes to help both her patients and her trainees find a path to better health and happiness. To keep herself in great health, Dr. Yu enjoys playing the piano, photography, scuba diving, adventure travel (all the more adventurous with her three children in tow!), and spending time with her family and friends.
-
Ilana Rachel Yurkiewicz
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Ilana Yurkiewicz is a Clinical Associate Professor of Medicine at Stanford University School of Medicine in the Division of Primary Care and Population Health. Board certified in internal medicine, hematology, and oncology, she co-directs Stanford’s Primary Care for Cancer Survivorship Program, an innovative clinic that cares for cancer survivors and patients at elevated risk. She is also an award-winning medical journalist and Stanford’s inaugural Physician-Journalist in Residence.
Her academic and clinical work centers on developing new models of care that bridge oncology and primary care. She has built programs to provide coordinated, longitudinal care for patients during and after cancer treatment and those with inherited cancer predispositions.
As a physician-journalist, she is the author of the nationally acclaimed book Fragmented: A Doctor’s Quest to Piece Together American Health Care (W.W. Norton, 2023). Her writing has also appeared in The Best American Science and Nature Writing, The Atlantic, Scientific American, TIME, STAT, Undark, and other outlets. She received a Folio Award for best healthcare column and was shortlisted for the Cancer Journalism Award.
She is Faculty Director of the annual Big Ideas in Medicine conference, which convenes leaders across fields to examine pressing challenges in health and society. She advises startups focused on cancer survivorship and prevention. As Associate Medical Director of Stanford’s Internal Medicine Clinic, she oversees the largest primary care clinic for Stanford residents. She teaches core concepts of cancer survivorship and primary care to residents, medical students, fellows, and faculty.
Her research focuses on designing new approaches to cancer survivorship delivery, and she leads a research team evaluating their implementation in practice. Her work has been published in the New England Journal of Medicine, Journal of Clinical Oncology, Genetics in Medicine, and other peer-reviewed journals. She has presented nationally at meetings including the Society of General Internal Medicine, American Society of Hematology, and National Society of Genetic Counselors. She has also served on the editorial board of Hematology News.
Earlier in her career, Dr. Yurkiewicz interned with the Presidential Commission for the Study of Bioethical Issues and contributed to white papers on ethical challenges in medicine. She is a member of the American College of Physicians and an associate member of the American Society of Clinical Oncology and American Society of Hematology. -
Roham Zamanian
James and Yvonne Wood Professor of Pulmonary Vascular Medicine
Current Research and Scholarly Interests1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.
2. Prevalence and Treatment of Insulin Resistance in PAH.
3. Role of inflammation and proteomic signature in PAH
4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.
5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension
6. Assessment of microvascular function in PAH. -
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
